Exact Mass: 339.1877424

Exact Mass Matches: 339.1877424

Found 112 metabolites which its exact mass value is equals to given mass value 339.1877424, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nalmefene

NALMEFENE-HCl

C21H25NO3 (339.18343400000003)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BB - Drugs used in alcohol dependence D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist

   

Xamoterol

Xamoterol hemifumarate

C16H25N3O5 (339.179412)


C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists Same as: D06328

   

NCIOpen2_009010

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

C21H25NO3 (339.18343400000003)


   

Methylergonovine

Methylergometrine

C20H25N3O2 (339.194667)


G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

Methylergonovine

(4R,7R)-N-[(2S)-1-hydroxybutan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide

C20H25N3O2 (339.194667)


Methylergonovine is only found in individuals that have used or taken this drug. It is a homolog of ergonovine containing one more CH2 group. (Merck Index, 11th ed)Methylergonovine acts directly on the smooth muscle of the uterus and increases the tone, rate, and amplitude of rhythmic contractions through binding and the resultant antagonism of the dopamine D1 receptor. Thus, it induces a rapid and sustained tetanic uterotonic effect which shortens the third stage of labor and reduces blood loss. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02A - Uterotonics > G02AB - Ergot alkaloids C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


Dehydropipernonaline is found in herbs and spices. Dehydropipernonaline is isolated from fruits of Piper longum (long pepper). Isolated from fruits of Piper longum (long pepper). Dehydropipernonaline is found in herbs and spices and pepper (spice).

   

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C20H25N3O2 (339.194667)


   

Edivoxetine

(R)-2-(5-Fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethanol

C18H26FNO4 (339.18457680000006)


   

1',3'-Dimethylspiro[1,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine-2,4'-1,3-diazinane]-2'-one

1,5-dimethyl-17-oxa-7-azaspiro[1,5-diazinane-2,4-tetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadecane]-1(10),11,13,15-tetraen-6-one

C20H25N3O2 (339.194667)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Nalmefene

4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol

C21H25NO3 (339.18343400000003)


   

2-Dehydrodeacetylheterophylloidine

2-Dehydrodeacetylheterophylloidine

C21H25NO3 (339.18343400000003)


   
   

2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one

2,6-bis(4-methoxyphenyl)-3,5-dimethylpiperidin-4-one

C21H25NO3 (339.18343400000003)


   
   
   

n,n-dimethyl-2-(2,3,4-trimethoxyphenanthren-1-yl)ethanamine

n,n-dimethyl-2-(2,3,4-trimethoxyphenanthren-1-yl)ethanamine

C21H25NO3 (339.18343400000003)


   
   
   
   
   
   
   

Pimelic Diphenylamide 106

N1-(2-aminophenyl)-N7-(4-methylphenyl)-heptanediamide

C20H25N3O2 (339.194667)


   
   
   

BML-210

N-(2-aminophenyl)-N-phenyl-octanediamide

C20H25N3O2 (339.194667)


   
   
   

Methylergometrine

Methylergometrine

C20H25N3O2 (339.194667)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.459 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.457 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.450 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.451

   
   
   
   
   
   
   
   
   
   

Dehydropipernonaline

(2E,4E,8E)-9-(2H-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


   

Dodecyl 3-amino-4-chlorobenzoate

Dodecyl 3-amino-4-chlorobenzoate

C19H30ClNO2 (339.196495)


   
   

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

TERT-BUTYL 3-(3-(BENZYLOXY)PHENYL)AZETIDINE-1-CARBOXYLATE

C21H25NO3 (339.18343400000003)


   

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

1H-Indole-2-carboxaldehyde,2,3-dihydro-2-hydroxy-1,3,3-trimethyl-,(4-methoxyphenyl)methylhydrazone

C20H25N3O2 (339.194667)


   

Piperilate

2-piperidin-1-ylethyl 2-hydroxy-2,2-diphenylacetate

C21H25NO3 (339.18343400000003)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

2-(2-Hydroxy-4-octyloxyphenyl)-[2H]-benzotriazole

C20H25N3O2 (339.194667)


   

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

Piperazine, 1-[1-[(4-chloro-2-fluorophenyl)methyl]-4-piperidinyl]-2-ethyl-, (2S)

C18H27ClFN3 (339.1877424)


   

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

(S)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794352)


   

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

6-Bromo-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one

C21H25NO3 (339.18343400000003)


   

azanium,cumene,furan-2,5-dione,styrene

azanium,cumene,furan-2,5-dione,styrene

C21H25NO3+ (339.18343400000003)


   

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

(R)-Tetrahydro-1,3,3-triphenyl-1H,3H-pyrrolo[1,2-c][1,3,2]oxaborole

C23H22BNO (339.1794352)


   

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

ETHYL 4-(4-PENTYLOXYBENZYLIDENEAMINO)BENZOATE

C21H25NO3 (339.18343400000003)


   
   
   

Edivoxetine

Edivoxetine

C18H26FNO4 (339.18457680000006)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

2-[3-(3-Hydroxy-3-methylbutyl)benzoyl]-1,2,3,4-tetrahydro-4-isoquinolinol

C21H25NO3 (339.18343400000003)


   

N1-(2-aminophenyl)-N8-phenyloctanediamide

N1-(2-aminophenyl)-N8-phenyloctanediamide

C20H25N3O2 (339.194667)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

(2s)-1-[1-(4-Phenylbutanoyl)-L-Prolyl]pyrrolidine-2-Carbonitrile

1-[1-(4-phenylbutanoyl)pyrrolidine-2-carbonyl]pyrrolidine-2-carbonitrile

C20H25N3O2 (339.194667)


   

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

(2S)-2-[[(2S,3S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoic acid

C15H25N5O4 (339.190645)


   

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

N-[1-(1-hexyl-2-benzimidazolyl)ethyl]-2-furancarboxamide

C20H25N3O2 (339.194667)


   

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

1-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-2-phenyl-1-butanone

C21H25NO3 (339.18343400000003)


   

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

4-Hydroxy-1,7,7-trimethyl-3-(2,4,6-trimethylphenyl)-6,8-dihydroquinoline-2,5-dione

C21H25NO3 (339.18343400000003)


   
   
   
   
   
   

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

2-(1,1-Dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate

C21H25NO3 (339.18343400000003)


   

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3S,4R)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.194667)


   

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2R,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.194667)


   

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

1-[(2S,3R,4S)-2-(ethylaminomethyl)-4-(hydroxymethyl)-3-phenyl-1-azetidinyl]-2-(2-pyridinyl)ethanone

C20H25N3O2 (339.194667)


   
   
   
   
   
   
   

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

C21H25NO3 (339.18343400000003)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

PF-670462 free base(2+)

PF-670462 free base(2+)

C19H22FN5+2 (339.1859144)


   

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

(6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C20H25N3O2 (339.194667)


   

Methergine

Methergine

C20H25N3O2 (339.194667)


D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

3-(2-Propenyloxy)estra-1,3,5(10)-triene-16,17-dione 16-oxime

Estra-1,3,5(10)-triene-16,17-dione, 3-(2-propenyloxy)-, 16-oxime

C21H25NO3 (339.18343400000003)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide

C20H25N3O2 (339.194667)


   

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

2-Methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid

C21H25NO3 (339.18343400000003)


   
   

KYP-2047

KYP-2047

C20H25N3O2 (339.194667)


KYP-2047 is a potent and BBB-penetrating prolyl-oligopeptidase (POP) inhibitor, with an Ki value of 0.023 nM. KYP-2047 reduces glioblastoma proliferation through angiogenesis and apoptosis modulation[1][2].

   

SEN12333

SEN12333

C20H25N3O2 (339.194667)


SEN 12333 (WAY-317538) is a potent, selective and orally active α7 nAChR agonist. SEN12333 displays high affinity for the rat α7 nAChRs expressed in GH4C1 cells (K>i=260 nM) and acts as full agonist in functional Ca2+ flux studies (EC50=1.6 μM). SEN 12333 is used for AD and schizophrenia research[1].

   

10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl 1-methylpyrrolidine-2-carboxylate

10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl 1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.196495)


   

2-methoxy-5-methyl-6-[(1e,3e)-3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

2-methoxy-5-methyl-6-[(1e,3e)-3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

C21H25NO3 (339.18343400000003)


   

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.196495)


   

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


   

(6r,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

(6r,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.18343400000003)


   

(1s,5r,8r,9s,11r,14s,17s,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

(1s,5r,8r,9s,11r,14s,17s,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

C21H25NO3 (339.18343400000003)


   

1-[(2r)-2-hydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-2,9-dihydro-1h-carbazole-3,4-dione

1-[(2r)-2-hydroxypropyl]-2-methyl-6-(3-methylbut-2-en-1-yl)-2,9-dihydro-1h-carbazole-3,4-dione

C21H25NO3 (339.18343400000003)


   

(6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

(6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.18343400000003)


   

dimethyl[2-(3,4,8-trimethoxyphenanthren-1-yl)ethyl]amine

dimethyl[2-(3,4,8-trimethoxyphenanthren-1-yl)ethyl]amine

C21H25NO3 (339.18343400000003)


   

(3r,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(3r,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.196495)


   

4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.18343400000003)


   

(2e,4z,8e)-9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

(2e,4z,8e)-9-(2h-1,3-benzodioxol-5-yl)-1-(piperidin-1-yl)nona-2,4,8-trien-1-one

C21H25NO3 (339.18343400000003)


   

(1r,5r,8r,9s,11s,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

(1r,5r,8r,9s,11s,14r,17r,18r)-5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

C21H25NO3 (339.18343400000003)


   

(3s,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

(3s,7e,9e)-10-chloro-2,2-dimethyl-5-methylidenedeca-7,9-dien-3-yl (2s)-1-methylpyrrolidine-2-carboxylate

C19H30ClNO2 (339.196495)


   

2-methoxy-5-methyl-6-[3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

2-methoxy-5-methyl-6-[3-methyl-4-(1h-pyrrol-2-yl)buta-1,3-dien-1-yl]-3-(2-methylbut-3-en-2-yl)pyran-4-one

C21H25NO3 (339.18343400000003)


   

dimethyl[2-(2,3,4-trimethoxyphenanthren-1-yl)ethyl]amine

dimethyl[2-(2,3,4-trimethoxyphenanthren-1-yl)ethyl]amine

C21H25NO3 (339.18343400000003)


   

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-6,16,19-trione

C21H25NO3 (339.18343400000003)


   

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

5,7-dimethyl-12-methylidene-7-azahexacyclo[9.6.2.0¹,⁸.0⁵,¹⁷.0⁹,¹⁴.0¹⁴,¹⁸]nonadecane-3,10,16-trione

C21H25NO3 (339.18343400000003)


   

(4s,5r,8r,9s,10s)-3-hydroxy-5,9-dimethyl-14-oxa-7-azahexacyclo[15.2.1.1⁷,¹⁰.0⁴,⁸.0⁹,¹⁹.0¹³,¹⁸]henicosa-1(19),13(18),17(20)-trien-2-one

(4s,5r,8r,9s,10s)-3-hydroxy-5,9-dimethyl-14-oxa-7-azahexacyclo[15.2.1.1⁷,¹⁰.0⁴,⁸.0⁹,¹⁹.0¹³,¹⁸]henicosa-1(19),13(18),17(20)-trien-2-one

C21H25NO3 (339.18343400000003)


   

(6s,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

(6s,6ar,8r,10s,10ar)-4-(4-hydroxyphenyl)-6,8,10-trimethyl-6h,6ah,7h,8h,9h,10h,10ah-isochromeno[4,3-c]pyridin-1-ol

C21H25NO3 (339.18343400000003)